New insights into coumarin-based MAO inhibitors for neurodegenerative diseases

Post author:admin
Post published:February 27, 2025
Post category:uncategorized

Announcing a new publication for Acta Materia Medica journal. Monoamine oxidase (MAO) is a useful target in the treatment of neurodegenerative diseases and depressive disorders.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

New project launched to accelerate development and accessibility of H5N1 mRNA vaccine candidates

Global study reveals shifting trends in ovarian cancer incidence by subtype and region

Newly discovered adhesion GPCR mayo controls midgut development in Drosophila

Helpful Links

Subscribe To Us